Premium
Hot Features
Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-05-28 | Mr. Richard Andrew WursterCEO, President & Director | 21,96k | 1,85M | Achat | 84,23 | 223,00k | 10,92% |
| 2026-05-22 | Mr. Charles R. SchwabInitié | -210,00k | 0,00 | Other Disposition | - | 14,46M | -1,43% |
| 2026-05-21 | Ms. Joan T. DeaIndependent Director | -835,00 | 0,00 | Other Disposition | - | 22,77k | -3,54% |
| 2026-05-15 | Mr. Charles R. SchwabInitié | -5,30k | 0,00 | Other Disposition | - | 14,67M | -0,04% |
| 2026-05-13 | Mr. Arun SarinIndependent Director | 5,37k | 155,40k | Derivative Exercise and Retained Stock | 28,96 | 30,58k | 21,28% |
| 2026-05-13 | Mr. Arun SarinIndependent Director | -2,50k | 155,51k | Derivative Exercise and Sale | 28,96 - 91,16 | 30,58k | - |
| 2026-05-05 | Ms. Carolyn Schwab-PomerantzDirector | -9,91k | 600,96k | Derivative Exercise and Sale | 31,65 - 92,29 | 1,85M | - |
| 2026-04-29 | Mr. Charles R. SchwabInitié | -168,74k | 15,41M | Vente | 90,49 - 91,86 | 15,79M | -1,06% |
| 2026-04-28 | Mr. Frank C. HerringerIndependent Director | 5,35k | 154,82k | Derivative Exercise and Retained Stock | 28,96 | 234,73k | 2,33% |
| 2026-04-28 | Mr. Frank C. HerringerIndependent Director | -2,52k | 155,33k | Derivative Exercise and Sale | 28,96 - 90,60 | 234,73k | - |
| 2026-04-23 | Mr. Charles R. SchwabInitié | -72,90k | 6,58M | Vente | 90,00 - 90,50 | 15,96M | -0,45% |
| 2026-04-14 | Mr. Paul V. WoolwayMD & Chief Banking Officer | -15,88k | 745,77k | Derivative Exercise and Sale | 52,05 - 100,00 | 46,73k | - |
| 2026-04-14 | Mr. Jonathan M. CraigMD, Head of Investor Service & Head of Retail Investing | -21,75k | 1,14M | Derivative Exercise and Sale | 46,81 - 99,00 | - | - |
| 2026-04-14 | Mr. Nigel J. MurtaghMD & Chief Risk Officer | -41,30k | 1,94M | Derivative Exercise and Sale | 52,05 - 99,00 | 60,46k | - |
| 2026-03-24 | Mr. Stephen A. EllisIndependent Director | 9,77k | 281,69k | Derivative Exercise and Retained Stock | 28,38 - 28,96 | 99,92k | 10,83% |
| 2026-03-03 | Mr. Nigel J. MurtaghMD & Chief Risk Officer | -7,20k | 681,45k | Automatic Disposition | 94,43 - 94,90 | 60,46k | -10,65% |
| 2026-03-03 | Mr. Jonathan M. CraigMD, Head of Investor Service & Head of Retail Investing | -14,48k | 1,37M | Automatic Disposition | 94,42 - 94,89 | 0,00 | -100,00% |
| 2026-03-03 | Mr. Dennis Willard HowardMD and Chief Technology, Operations & Data Officer | -10,11k | 956,23k | Automatic Disposition | 94,43 - 94,88 | 10,47k | -49,12% |
| 2026-03-02 | Mr. Paul V. WoolwayMD & Chief Banking Officer | -15,88k | 684,05k | Derivative Exercise and Sale | 52,05 - 96,00 | 46,73k | - |
| 2026-03-03 | Mr. Paul V. WoolwayMD & Chief Banking Officer | -6,13k | 579,57k | Automatic Disposition | 94,41 - 94,89 | 46,73k | -11,59% |
| 2026-03-01 | Mr. Paul V. WoolwayMD & Chief Banking Officer | -2,03k | 183,32k | Sale to Issuer | 90,31 | 46,73k | -4,16% |
| 2026-03-01 | Mr. Jonathan M. CraigMD, Head of Investor Service & Head of Retail Investing | -11,15k | 1,06M | Sale to Issuer | 95,31 | 14,48k | -43,51% |
| 2026-03-01 | Mr. Nigel J. MurtaghMD & Chief Risk Officer | -9,11k | 868,13k | Sale to Issuer | 95,31 | 67,55k | -11,88% |
| 2026-03-01 | Mr. Dennis Willard HowardMD and Chief Technology, Operations & Data Officer | -6,20k | 591,27k | Sale to Issuer | 95,31 | 10,11k | -38,03% |
| 2026-03-01 | Mr. Charles R. SchwabInitié | -15,28k | 1,46M | Sale to Issuer | 95,31 | 16,03M | -0,10% |
| 2026-03-01 | Mr. Walter William BettingerCo-Chairman | -60,74k | 5,79M | Sale to Issuer | 95,31 | 623,94k | -8,87% |
| 2026-03-01 | Mr. Richard Andrew WursterCEO, President & Director | -22,88k | 2,18M | Sale to Issuer | 95,31 | 200,78k | -10,23% |
| 2026-03-01 | Mr. Peter J. MorganMD, General Counsel & Corporate Secretary | -4,31k | 410,86k | Sale to Issuer | 95,31 | 7,65k | -36,04% |
| 2026-02-27 | Mr. Jonathan Scott BeattyMD & Head of Schwab Advisor Services | -2,03k | 193,45k | Vente | 95,30 | 25,50k | -7,37% |
| 2026-02-26 | Mr. Stephen A. EllisIndependent Director | -10,73k | 1,04M | Vente | 96,57 | 83,50k | -11,38% |
| 2026-02-25 | Mr. Dennis Willard HowardMD and Chief Technology, Operations & Data Officer | -27,90k | 862,76k | Derivative Exercise and Sale | 64,10 - 95,02 | 0,00 | - |
| 2026-02-09 | Mr. Charles R. SchwabInitié | -60,00k | 0,00 | Other Disposition | - | 16,01M | -0,37% |
| 2026-02-06 | Mr. Walter William BettingerCo-Chairman | -67,51k | 4,14M | Derivative Exercise and Sale | 42,99 - 104,25 | 542,93k | - |
| 2026-02-06 | Mr. Christopher Vincent DoddsIndependent Director | -11,83k | 479,17k | Derivative Exercise and Sale | 51,97 - 104,55 | 449,41k | - |
| 2026-02-03 | Mr. Charles R. SchwabInitié | -164,60k | 17,08M | Vente | 103,74 - 103,81 | 16,07M | -1,01% |
| 2026-02-03 | Mr. Walter William BettingerCo-Chairman | -257,41k | 15,71M | Derivative Exercise and Sale | 42,99 - 104,25 | 542,93k | - |
| 2026-02-02 | Mr. Peter J. MorganMD, General Counsel & Corporate Secretary | -7,60k | 287,96k | Derivative Exercise and Sale | 66,47 - 104,38 | 700,00 | - |
| 2026-01-29 | Mr. Charles R. SchwabInitié | -145,65k | 15,03M | Vente | 103,16 | 16,24M | -0,89% |
| 2026-01-28 | Mr. Charles R. SchwabInitié | -71,44k | 7,37M | Vente | 103,20 - 103,22 | 16,38M | -0,43% |
| 2026-01-22 | Ms. Carolyn Schwab-PomerantzDirector | -42,87k | 4,51M | Vente | 105,02 - 105,25 | 1,85M | -2,27% |
| 2026-01-22 | Mr. Jonathan Scott BeattyMD & Head of Schwab Advisor Services | -2,00k | 117,22k | Derivative Exercise and Sale | 46,39 - 105,00 | 27,53k | - |
| 2025-12-23 | Mr. Jonathan Scott BeattyMD & Head of Schwab Advisor Services | -2,00k | 111,24k | Derivative Exercise and Sale | 46,39 - 102,01 | 27,53k | - |
| 2025-12-16 | Mr. Stephen A. EllisIndependent Director | 1,92k | 61,47k | Derivative Exercise and Retained Stock | 31,98 | 100,55k | 1,95% |
| 2025-11-19 | Mr. Charles Anthony RuffelIndependent Director | -8,37k | 0,00 | Other Disposition | - | 18,87k | -30,74% |
| 2025-11-12 | Mr. Nigel J. MurtaghMD & Chief Risk Officer | -1,03k | 0,00 | Other Disposition | - | 60,35k | -1,68% |
| 2025-11-12 | Mr. Jonathan Scott BeattyMD & Head of Schwab Advisor Services | -3,07k | 158,55k | Derivative Exercise and Sale | 46,39 - 98,00 | 27,53k | - |
| 2025-11-13 | Ms. Paula A. SneedIndependent Director | -8,68k | 0,00 | Other Disposition | - | 100,98k | -7,92% |
| 2025-11-12 | Mr. Charles R. SchwabInitié | -52,50k | 0,00 | Other Disposition | - | - | - |
| 2025-11-10 | Ms. Carolyn Schwab-PomerantzDirector | -298,00 | 0,00 | Other Disposition | - | 1,89M | -0,02% |
| 2025-11-10 | Mr. Walter William BettingerCo-Chairman | -61,39k | 0,00 | Other Disposition | - | 542,65k | -10,16% |
| 2025-11-10 | Mr. Paul V. WoolwayMD & Chief Banking Officer | -1,09k | 0,00 | Other Disposition | - | 46,70k | -2,28% |
| 2025-11-07 | Mr. Jonathan M. CraigMD, Head of Investor Service & Head of Retail Investing | -35,19k | 1,88M | Derivative Exercise and Sale | 41,98 - 95,35 | 0,00 | - |
| 2025-10-28 | Mr. Charles R. SchwabInitié | -109,15k | 10,28M | Vente | 94,00 - 94,52 | - | - |
| 2025-10-29 | Mr. Paul V. WoolwayMD & Chief Banking Officer | -3,82k | 0,00 | Other Disposition | - | 46,99k | -7,52% |
| 2025-10-23 | Mr. Charles R. SchwabInitié | -50,35k | 0,00 | Other Disposition | - | - | - |
| 2025-10-02 | Ms. Carolyn Schwab-PomerantzDirector | -24,00k | 2,22M | Automatic Disposition | 92,55 | 1,89M | -1,26% |
| 2025-10-01 | Mr. Paul V. WoolwayMD & Chief Banking Officer | -3,21k | 299,11k | Automatic Disposition | 93,04 - 93,74 | 50,81k | -5,93% |
| 2025-09-23 | Mr. Stephen A. EllisIndependent Director | 2,11k | 60,10k | Derivative Exercise and Retained Stock | 28,55 | 98,35k | 2,19% |
| 2025-09-04 | Ms. Carolyn Schwab-PomerantzDirector | -24,00k | 2,32M | Automatic Disposition | 96,64 | 1,91M | -1,24% |
| 2025-09-02 | Mr. Paul V. WoolwayMD & Chief Banking Officer | -3,21k | 305,13k | Automatic Disposition | 95,20 | 54,02k | -5,60% |
| 2025-08-28 | Mr. Jonathan Scott BeattyMD & Head of Schwab Advisor Services | -6,14k | 309,79k | Derivative Exercise and Sale | 46,39 - 96,81 | 27,53k | - |
| 2025-08-27 | Mr. Jonathan Scott BeattyMD & Head of Schwab Advisor Services | -3,30k | 320,31k | Vente | 97,18 | 27,53k | -10,69% |
| 2025-08-27 | Mr. Peter J. MorganMD, General Counsel & Corporate Secretary | -50,02k | 1,68M | Derivative Exercise and Sale | 46,39 - 97,00 | 601,00 | - |
| 2025-08-26 | Mr. Charles R. SchwabInitié | -273,00k | 26,44M | Vente | 96,67 - 97,04 | - | - |
| 2025-08-25 | Ms. Carolyn Schwab-PomerantzDirector | -13,54k | 1,30M | Vente | 96,06 | 1,94M | -0,69% |
| 2025-08-07 | Mr. Charles R. SchwabInitié | -155,87k | 15,07M | Vente | 96,02 - 96,84 | - | - |
| 2025-08-07 | Ms. Carolyn Schwab-PomerantzDirector | -24,00k | 2,32M | Automatic Disposition | 96,68 - 97,22 | 1,95M | -1,22% |
| 2025-08-01 | Mr. Paul V. WoolwayMD & Chief Banking Officer | -3,29k | 316,04k | Vente | 96,06 | 57,22k | -5,44% |
| 2025-07-29 | Mr. Walter William BettingerCo-Chairman | -173,88k | 17,19M | Vente | 98,84 | 603,96k | -22,35% |
| 2025-07-29 | Mr. Richard Andrew WursterCEO, President & Director | -20,50k | 2,03M | Vente | 99,16 | 161,52k | -11,26% |
| 2025-07-29 | Mr. Nigel J. MurtaghMD & Chief Risk Officer | -24,10k | 1,35M | Derivative Exercise and Sale | 41,98 - 97,91 | 61,37k | - |
| 2025-07-29 | Ms. Joan T. DeaIndependent Director | -513,00 | 0,00 | Other Disposition | - | 23,61k | -2,13% |
| 2025-07-03 | Ms. Carolyn Schwab-PomerantzDirector | -24,00k | 2,20M | Automatic Disposition | 91,59 | 1,97M | -1,20% |
| 2025-07-01 | Mr. Jonathan Scott BeattyMD & Head of Schwab Advisor Services | -1,04k | 93,91k | Sale to Issuer | 90,74 | 24,38k | -4,07% |
| 2025-07-01 | Mr. Paul V. WoolwayMD & Chief Banking Officer | -3,29k | 299,22k | Automatic Disposition | 90,95 | 64,11k | -4,88% |
| 2025-06-24 | Mr. Stephen A. EllisIndependent Director | 1,85k | 61,37k | Derivative Exercise and Retained Stock | 33,12 | 95,98k | 1,97% |
| 2025-06-18 | Mr. Nigel J. MurtaghMD & Chief Risk Officer | -20,87k | 981,38k | Derivative Exercise and Sale | 42,99 - 90,01 | 61,37k | - |
| 2025-06-18 | Mr. Paul V. WoolwayMD & Chief Banking Officer | -10,13k | 437,55k | Derivative Exercise and Sale | 46,81 - 90,01 | 67,40k | - |
| 2025-06-05 | Ms. Carolyn Schwab-PomerantzDirector | -24,00k | 2,09M | Automatic Disposition | 87,25 | 2,00M | -1,19% |
| 2025-06-03 | Mr. Michael Daniel VerdeschiMD & CFO | -5,89k | 515,44k | Sale to Issuer | 87,54 | 53,96k | -9,84% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
